Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The goal of this clinical trial is to evaluate the effectiveness of REVISE (REalidad Virtual Inmersiva y SExualidad), an immersive virtual reality (IVR) intervention designed to promote empathy and reduce sexual harassment behaviors in heterosexual cisgender men.
The main questions that this study aims to answer are as follows.
Does experiencing gender swapping in IVR increase empathy towards survivors of sexual harassment?
Does the intervention modify attitudes toward gender roles and sexual harassment?
Researchers will compare the three experimental groups to evaluate the effects of IVR:
Participants will:
Full description
This study is a randomized controlled trial (RCT) designed to evaluate the efficacy of REVISE (REalidad Virtual Inmersiva y SExualidad), an immersive virtual reality (IVR) intervention, to promote empathy and reduce sexual harassment behaviors in heterosexual cisgender men. This study will assess whether experiencing sexual harassment from a first-person perspective using IVR embodiment techniques can lead to changes in attitudes and behaviors related to gender roles and sexual violence.
Study Design
Design: Randomized controlled trial (RCT) with a 1:1:1 allocation ratio.
Population: 90 heterosexual cisgender couples (180 participants) aged 18-39 years.
Study Setting: This study will be conducted in a controlled laboratory environment at the Interdisciplinary Research and Innovation Hub of the Universitat Oberta de Catalunya (UOC), equipped with advanced VR and physiological tracking technologies.
Conditions:
Intervention Duration: One VR session (~60 minutes) with pre- and post-intervention assessments and a three-month follow-up.
Intervention Procedures
Pre-intervention assessment
VR Intervention:
Post-intervention assessment
Three-month follow-up:
Outcome Measures
Sample Size Justification A sample of 90 couples (180 individuals) was determined based on an estimated effect size of d = 0.5, an alpha risk of 0.05, and a power of 0.86. Participants will be randomized using block randomization (block sizes of 3 or 6) to ensure balance across the conditions.
Data Management and Quality Assurance
Data Collection
Data Validation and Security
Missing Data Handling:
Statistical Analysis Plan
Primary Analysis:
Secondary Analyses:
Ethical Considerations
Dissemination Plan
The findings will be as follows:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
180 participants in 3 patient groups
Loading...
Central trial contact
Pablo Vallejo Medina, Doctor; Adrián Montesano, Doctor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal